Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/19/2025

Management of Paroxysmal Tachycardia with Metoprolol

Introduction to Metoprolol Dosage

  • The maximum daily dose of metoprolol XR for paroxysmal tachycardia is 400 mg once daily, according to the American Heart Association guidelines 1
  • The initial dose of metoprolol succinate (XR/extended-release) should be 50 mg once daily, with gradual increases based on clinical response 1
  • For acute management of paroxysmal tachycardia episodes, IV metoprolol can be administered at 5 mg over 1-2 minutes, repeated every 5 minutes to a maximum of 15 mg, as recommended by the American College of Cardiology 2

Mechanism of Action and Effects

  • Metoprolol is a beta-1 selective adrenergic receptor blocker that reduces the effects of circulating catecholamines, heart rate, and AV node conduction, and decreases blood pressure, acting as a negative inotrope 2

Indications and Efficacy

  • Metoprolol has demonstrated effectiveness in stable, narrow-complex tachycardias uncontrolled by adenosine or vagal maneuvers, control of ventricular rate in atrial fibrillation or flutter, and certain forms of polymorphic VT, according to the European Society of Cardiology 2

Contraindications and Precautions

  • Metoprolol should be avoided in patients with AV block greater than first degree or SA node dysfunction (without pacemaker), decompensated systolic heart failure, hypotension, reactive airway disease/asthma, and pre-excited atrial fibrillation or flutter, as recommended by the American Heart Association 1, 2
  • When using metoprolol for paroxysmal tachycardia, monitor for hypotension, bradycardia, precipitation or worsening of heart failure, and bronchospasm in susceptible patients, according to the American College of Cardiology 1, 2

Potential Pitfalls and Interactions

  • Abrupt withdrawal of metoprolol can lead to rebound tachycardia and worsening of symptoms, and should be avoided, as warned by the European Heart Journal 3
  • Inadequate initial dosing, failure to recognize pre-excitation, overlooking comorbidities, and drug interactions can also lead to adverse effects, and should be carefully managed, according to the American Heart Association 1